Matrix Laboratories (Delisted) share news and announcements
BSE: 524794
Last traded ₹209.35 on 13 Aug 2009
Delisted on 21 Aug 2009.
Matrix Laboratories share news and announcements
107 announcements, routine notices left out, newest first. Page 2 of 3.
Jul 2008
30 Jul · Updates
Board of Directors at their meeting held on July 29, 2008, the Board approved issue of a Final Notice to the Shareholders holding 23,218 partly paid up Equity Shares of Rs.2/- each, advising them to remit the calls-in-arrears along with interest on or before September 08, 2008.26 Jul · Updates
Abstract of terms issued to the members of the Company pursuant to Section 302 of the Companies Act, 1956 regarding appointment of Mr. Jagdish Vishwanath Dore, Chief Executive Officer as Managing Director. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.18 Jul · Board meeting
Meeting on 29 Jul 2008: “Unaudited Financial Results for the Qtr ended June 30, 2008”1 Jul · Business
Press release dated June 30, 2008, titled "Jagdish Dore' inducted into the Board as Managing Director of Matrix Laboratories; Rajiv Malik Relocating to U.S. in current Assignment as Head of Global Technical Operations for Mylan". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.1 Jul · Business
Press release dated June 30, 2008, titled "Matrix announces its Annual Results for year ended 31st March, 2008". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.1 Jul · Results
Standalone Results for the year ended on 31-MAR-2008 as follows: Net Sales of Rs. 97876.4 lacs for year ending on 31-MAR-2008 against Rs. 74950.6 lacs for the year ending on 31-MAR-2007. Net Profit / (Loss) of Rs. (29835.7) lacs for the year ending on 31-MAR-2008 against Rs. 9961.3 lacs for the year ending on 31-MAR-2007.1 Jul · Results
Consolidated Results for the year ended on 31-MAR-2008 as follows: Net Sales of Rs. 176158.9 lacs for year ending on 31-MAR-2008 against Rs. 164802.7 lacs for the year ending on 31-MAR-2007. Net Profit / (Loss) of Rs. (45692.7) lacs for the year ending on 31-MAR-2008 against Rs. 7631 lacs for the year ending on 31-MAR-2007.
Jun 2008
20 Jun · Board meeting
Inter-alia to consider and approve the Audited Financial Results of the Company for the Fourth Quarter and Year ended March 31, 2008.
May 2008
13 May · Updates
Vide its letter dated May 12, 2008 that "Mylan Inc., USA, (Mylan) the ultimate holding company of Matrix Laboratories Limited (Matrix) has reported today (12th May, in the US), the unaudited interim consolidated financials of Mylan for the quarter ended 31st March, 2008 under US GAAP reporting, which inter alia included the following unaudited details of Matrix: Segment profitability (on a US GAAP basis) of $3,617,000 for the three months ended 31 March, 2008. Please note that financial results of Matrix for the quarter ended / year ended 31st March, 2008 are yet to be reported under Indian GAAP and the above information is as reported by Mylan, which is being forwarded to you by Matrix for your information. Please also note that Indian GAAP and US GAAP differ in certain significant respects, and the US GAAP figures reported above may not be indicative of the results under Indian GAAP."9 May · Updates
Vide its letter dated May 09, 2008 that "Mylan Inc., USA, (Mylan) the ultimate holding company of Matrix Laboratories Limited (Matrix) has reported today (8th May, in the U.S.), the unaudited interim consolidated financials of Mylan for the quarter ended 31st March, 2008 under US GAAP reporting, which inter alia included the following unaudited details of Matrix: Revenues for the three months ended 31 March, 2008 (on a US GAAP basis) of US $103 million, including third party sales of US$ 87.6 million. Please note that financial results of Matrix for the quarter ended / year ended 31st March, 2008 are yet to be reported under Indian GAAP and the above information is as reported by Mylan, which is being forwarded to you by Matrix for your information. Please also note that Indian GAAP and U.S. GAAP differ in certain significant respects, and the US GAAP figures reported above may not be indicative of the results under Indian GAAP".
Apr 2008
25 Apr · Results
The Company will publish audited financial results for the financial year ending 31st March, 2008 within three months i.e. by 30th June, 2008, and hence we would not be publishing the unaudited financial results for the last quarter ended 31st March, 2008.23 Apr · Management
Mr Jagdish Viswanath Dore has joined Matrix Laboratories Limited as Chief Executive officer of the Company effective April 21, 2008.
Feb 2008
28 Feb · Business
Press release dated February 28, 2008, titled "Matrix to Pursue Strategic Alternatives including Potential Divestiture of Docpharma". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.28 Feb · Business
"Mr. Rajiv Malik, the incumbent Managing Director and Chief Executive Officer of Matrix Laboratories Limited will be relocated to U.S in connection with his employment by the parent company, Mylan Inc. He will be succeeded by Mr. Jagadish Dore. The effective dates for relocation/ date of joining will be finalised subsequently". Further the Company has also submitted to the exchange a copy of press release in this regard dated February 27, 2008, titled "Matrix Laboratories Announces Appointment of Jagdish Dore' as CEO". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2008
25 Jan · Results
Consolidated Results for the quarter ended on 31-DEC-2007 as follows: Net Sales of Rs. 45354 lacs for quarter ending on 31-DEC-2007 against Rs. 39525.2 lacs for the quarter ending on 31-DEC-2006. Net Profit / (Loss) of Rs. 1543.2 lacs for the quarter ending on 31-DEC-2007 against Rs. (87.4) lacs for the quarter ending on 31-DEC-2006.25 Jan · Business
Press release dated January 24, 2008, titled "Acquisition of Residual Holding in MChem Group of Companies, China". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.17 Jan · Board meeting
Inter alia, to, consider and approve the "Unaudited Financial Results" of the Company for the third quarter and nine months ended December 31, 2007.
Dec 2007
5 Dec · Business
Press release dated December 04, 2007 titled "Matrix announces tentative FDA Approval under PEPFAR for Tenofovir Disoproxil Fumarate Tablets". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Nov 2007
13 Nov · News Verification
News Verification : The media had reports that Mylan may come out with a delisting offer for Matrix and are looking at buying the residual stake. The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the officials of the company. Matrix Laboratories Limited has vide its letter inter-alia stated,"As on date Mylan Laboratories Inc.,USA is neither contemplating to buy residual stake nor delist the securities of the Company from the Stock Exchanges. Hence, the news item is incorrect and baseless."
Oct 2007
31 Oct · Management
Board of Directors of the Company at their meeting held on October 30, 2007 considered and approved the following items :- 1) Appointment of Prof. P V Indiresan as an Additional Director on the Board of the Company with effect from October 30, 2007; 2) Appointment of Prof. P. V. Indiresan as the member of the Audit Committee.31 Oct · Results
Standalone Results for the half year ended on 30-SEP-2007 as follows: Net Sales of Rs. 42799.3 lacs for half year ending on 30-SEP-2007 against Rs. 33665.5 lacs for the half year ending on 30-SEP-2006. Net Profit / (Loss) of Rs. 3943.2 lacs for the half year ending on 30-SEP-2007 against Rs. 3858.1 lacs for the half year ending on 30-SEP-2006.31 Oct · Results
Consolidated Results for the half year ended on 30-SEP-2007 as follows: Net Sales of Rs. 82342.6 lacs for half year ending on 30-SEP-2007 against Rs. 81533.8 lacs for the half year ending on 30-SEP-2006. Net Profit / (Loss) of Rs. 1695.9 lacs for the half year ending on 30-SEP-2007 against Rs. 4966.1 lacs for the half year ending on 30-SEP-2006.31 Oct · Results
Consolidated Results for the quarter ended on 30-SEP-2007 as follows: Net Sales of Rs. 37641 lacs for quarter ending on 30-SEP-2007 against Rs. 37317.8 lacs for the quarter ending on 30-SEP-2006. Net Profit / (Loss) of Rs. (992.5) lacs for the quarter ending on 30-SEP-2007 against Rs. 1585.9 lacs for the quarter ending on 30-SEP-2006.22 Oct · Board meeting
Inter alia to, consider and approve the "Unaudited Financial Results' for the second quarter and half year ended September 30, 2007.
Sep 2007
27 Sep · Allotment of Equity Shares
The Compensation Committee of the Board on 22nd September, 2007, by circulation, have allotted 45,300 Equity Shares of Rs. 2/- each under ESOP - 2004 Scheme. Consequent to the above allotment, the paid-up share capital of the Company has increased to Rs. 30,89,70,726/-20 Sep · Change of address of Registrar & Share Transfer Agent
Vide its letter dated September 19, 2007 that the address of the Registrar & Share Transfer Agent of the Company Viz., Venture Capital & Corporate Investments Limited is changed with immediate effect and the new address is as under: Venture Capital and Corporate Investments Limited, Unit: Matrix Laboratories Limited, 12-10-167, Bharat Nagar, Hyderabad-500 018, Phone no(s): 040-23818475/76, Fax no: 040-23868024.19 Sep · Miscellaneous
Abstract & Memorandum of Interest, in terms of Section 302 of the Companies Act, 1956, pertaining to variation in terms of remuneration of Mr Rajiv Malik, Managing Director & Chief Executive Officer. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Aug 2007
24 Aug · Business
Press release dated August 24, 2007 titled "Agreement to acquire residual holding in MChem Group of Companies, China". A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.17 Aug · Meeting
Proceedings of the Annual General Meeting of the Company held on July 16, 2007. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.6 Aug · Allotment of Equity Shares
The Compensation Committee of the Board on 3rd August, 2007, by circulation, have allotted 51,206 Equity Shares of Rs. 2/- each under ESOP - 2004 Scheme. Consequent to the above allotment, the paid-up share capital of the Company has increased to Rs. 30,88,80,126/-
Jul 2007
26 Jul · Management
Board of Directors of the Company at their meeting held on July 25, 2007 considered and approved the following items: (a) Appointment of Mr. Sandip Choudhury as Chief Financial Officer of the Company, effective July 09, 2007. (b) Resignation of Mr.N.Anjaneyulu as Company Secretary and Compliance Officer effective from the close of business hours of July 31, 2007; and (d) Appointment of Mrs. V. Sheela as Company Secretary and Compliance Officer of the Company, effective from August 01, 2007.26 Jul · Business
Press release, titled "Matrix Records Net Sales of Rs.4,470 Million And Net Profit of Rs.269 Million For Q1 FY 08". A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.26 Jul · Results
Consolidated Results for the quarter ended on 30-JUN-2007 as follows: Net Sales of Rs. 44701.6 lacs for quarter ending on 30-JUN-2007 against Rs. 44216 lacs for the quarter ending on 30-JUN-2006. Net Profit / (Loss) of Rs. 2688.4 lacs for the quarter ending on 30-JUN-2007 against Rs. 3380.2 lacs for the quarter ending on 30-JUN-2006.26 Jul · Results
Standalone Results for the quarter ended on 30-JUN-2007 as follows: Net Sales of Rs. 20610.1 lacs for quarter ending on 30-JUN-2007 against Rs. 19412.1 lacs for the quarter ending on 30-JUN-2006. Net Profit / (Loss) of Rs. 2579.2 lacs for the quarter ending on 30-JUN-2007 against Rs. 2897.2 lacs for the quarter ending on 30-JUN-2006.17 Jul · Board meeting
Meeting on 25 Jul 2007: “Unaudited financial results for quarter ended June 30, 2007”17 Jul · Meeting
All resolutions placed at the Annual General Meeting of the Company held on July 16, 2007, in terms of the Notice dated May 23, 2007, have been unanimously passed by the Members of the Company. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jun 2007
29 Jun · Meeting
Notice of the Annual General Meeting of the Members of the Company to be held on July 16, 2007. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.15 Jun · Allotment of shares
The Compensation Committee of the Board on 14th June, 2007, by circulation, have allotted 2,80,770 Equity Shares of Rs.2/- each under ESOP-2004 Scheme. Consequent to the above allotment, the paid-up share capital of the Company has increased to Rs.30,87,77,150/-
May 2007
24 May · Meeting
Board of Directors at their meeting held on May 23, 2007, considered and approved the following items: (1) To convene and conduct Annual General Meeting of the Company on July 16, 2007.(2) Closure of Register of Members and Share Transfer Books from July 11, 2007 to July 16, 2007 for the purpose of AGM.24 May · Business
Press release dated May 23, 2007, titled "Matrix Records Net Sales of Rs.16,480 Million And Net Profit of Rs.763 Million For FY 07". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.15 May · Board meeting
Inter- alia to consider and approve the Audited Financial Results of the Company for the Fourth Quarter and Year ended March 31, 2007.9 May · Business
Press release dated May 09, 2007, titled "Matrix signs agreement with Clinton Foundation for ARV Drugs". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Apr 2007
20 Apr · Results
Company shall publish Audited Financial Results within a period of 3 month for the year ended on March 31, 2007 i.e. on or before June 30, 2007.
Mar 2007
30 Mar · Allotment of shares
The Compensation Committee of the Board on 29th March, 2007 by circulation, have allotted 78,420 Equity Shares of Rs. 2/- each under ESOP - 2004 Scheme. Consequent to the above allotment, the paid-up share capital of the Company has increased to Rs. 30,82,15,610/-.14 Mar · E-mail ID for Investor Complaints
The Company has exclusively designated the following e-mail ID for redressal of investor's complaints - [email protected]1 Mar · Results
Notice of Declaration of Results of Postal Ballot in respect of the Resolution for Amendment to Articles of Association of the Company. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Feb 2007
23 Feb · Miscellaneous
Abstract of Memorandum of Interest pertaining to appointment of Mr. Rajiv Malik as Managing Director & Chief Executive Officer. A copy of the same shall be available on the NSE website (http://www.nseindia. com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.19 Feb · Allotment of shares
The Compensation Committee of the Board on 17th February, 2007 by circulation, have allotted 63,175 Equity Shares of Rs. 2/- each under ESOP - 2004 Scheme. Consequent to the above allotment, the paid-up share capital of the Company has increased to Rs. 30,80,58,770/-.1 Feb · Board meeting
January 31, 2007, that: "The Board of Directors of the Company at their meeting held on even date considered and approved the following items : Agreement dated January 31, 2007 with Mr. Rajiv Malik pursuant to which Mr. Malik will continue as the Managing Director and acting Chief Executive Officer of the Company on deputation from Mylan Laboratories Inc. (USA), for whom Mr. Malik serves as Head of Global Technical Operations. An abstract of the terms and conditions of Mr. Rajiv Malik's agreement with Matrix would be forwarded to the Members, as required under Section 302 of the Companies Act, 1956".1 Feb · Business
Press release, dated January 31, 2007, titled "Matrix records net sales of Rs. 3,953 million in Q3FY07." The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.